Pharma Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anthrax
Final EPA protocol testing of anthrax sporicidal completed
August 15th, 2005
EFoodSafety.com, Inc, (EFSF), a company improving food and health conditions, announced via its wholly owned subsidiary, Knock-Out Technologies, Ltd., that the final efficacy laboratory study requisite for EPA licensure on its anthrax sporicidal has been completed. The study conducted by Celsis Laboratory Group of St. Louis, Missouri (CEL.L), concluded that the sporicidal product eradicated with 100% efficacy the Bacillus subtilis and Clostridium sporogenes bacteria on both hard and porous surfaces. This final study mandated eradication of both Clostridium sporogenes and Bacillus subtilis on 360 replication plates for hard...
Source: Pharma Business Week (2005-08-15)
|
